A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors
Condition: Advanced Solid TumorsInterventions: Dietary Supplement: Conjugated Linoleic Acid; Drug: Conjugated Linoleic AcidSponsors: Dartmouth-Hitchcock Medical Center; National Cancer Institute (NCI)Terminated - verified March 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2009 Category: Research Source Type: clinical trials